ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients
Judith S. Currier, Carlee Moser, Joseph J. Eron, Kara W Chew, Davey M. Smith, Arzhang Cyrus Javan, David A. Wohl, Eric S. Daar, Michael D. Hughes, for the ACTIV-2/A5401 Study Team, Lara Hosey, Jhoanna Roa, Nilam Patel, Frontier Science, Bill Erhardt, Lorraine Waring, Diane Hessinger, Stacey Adams
Abstract
Clinical Trials Registration ClinicalTrials.gov Identifier: NCT04518410.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BetacoronavirusMedicineCoronavirus InfectionsPandemicIntensive care medicineClinical trialVirologyInternal medicineOutbreakInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Sepsis Diagnosis and Treatment